Essential Concepts in Patient Centricity
This course uses a faux product to introduce essential concepts of Patient Centricity including a comprehensive description of strategy.
This course uses a faux product to introduce essential concepts of Patient Centricity including a comprehensive description of strategy.
Last month, Medical Affairs and clinical experts from six organizations came together to help make clinical trials more accessible to and better understood by people facing vitiligo. You can do this in your therapeutic area.
MAPS speaks with MyHealthTeams Cofounder and CEO, Eric Peacock, about how health communities can help the biopharmaceutical industry develop new products that truly make a difference in patients’ lives.
This session will provide a learning opportunity for our audience by providing background on FDA’s Offices of Minority Health and Health Equity, and Women’s Health:
Through generation of Medical Insights, MA enhances its “third pillar” role within the pharmaceutical company and demonstrates value as a key driver in activities directly affecting patient outcomes.
At the end of this series of podcasts, the participant should be able to discuss the functions and activities of key internal partners and identify potential areas for compliant collaboration by MSLs with key internal partners.
In this episode of Partnering for Today and Tomorrow we discuss the functions and activities of key internal partners and how we identify potential areas for compliant collaboration by MSLs with key internal partners.
This session will provide a learning opportunity for our audience by describing:
Events of the last 12 months have driven the pharmaceutical industry to more comprehensively examine how it can address ethnic and racial disparities in health outcomes and clinical research access. It is well accepted that diversity of clinical trial participants is essential to ensure that the trial population is truly representative of the patients who will use the therapy, yet disparities in clinical trial participation remain. A multi-faceted approach is required to understand the critical barriers to clinical research access for patients from diverse backgrounds.
During this thought-provoking webinar, our panel of internationally renowned Patient Advisors and Diversity Experts will share their perspectives on diverse representation in clinical trials and key barriers to research access, and explore solutions to address these critical issues.
This program will:
Join this session to understand aligned HCP and patient education activities from the perspective of the current landscape, Medical Affairs support for aligned medical education and risk mitigation ensuring transparency, fairness and lawfulness.
• Explore the approach of aligning HCP education with patient education to optimize patient and healthcare outcomes
• Describe the different types of aligned HCP and patient education models
• Identify the risks and challenges of providing aligned HCP and patient education that is transparent, fair and lawful
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.